Unlock instant, AI-driven research and patent intelligence for your innovation.

Salification method for 2-(6-quinolineamino)-6-cyclopropylamino-9H-purine

A technology of cyclopropylamino and quinolineamino, applied in the field of 2--6-cyclopropylamino-9H-purine salt formation, can solve the problems of large side effects and poor selectivity

Inactive Publication Date: 2008-03-26
ZHEJIANG MEDICINE CO LTD XINCHANG PHAMACEUTICAL FACTORY +1
View PDF4 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, chemical drug therapy mainly has the disadvantages of poor selectivity and large side effects.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Salification method for 2-(6-quinolineamino)-6-cyclopropylamino-9H-purine
  • Salification method for 2-(6-quinolineamino)-6-cyclopropylamino-9H-purine

Examples

Experimental program
Comparison scheme
Effect test

example 1

[0014] Example 1 Preparation of hydrochloride (compound II)

[0015] Add compound III (p is tetrahydropyranyl) (1.0g), tetrahydrofuran (20ml) and 6 N HCl (0.9ml) into a 50ml one-necked flask, stir, heat up to reflux, reflux for 1.5h, and analyze the reaction by TLC Completely, stop stirring, and cool to room temperature naturally. It was filtered, washed 3 times with acetone, and dried in vacuum at 40° C. for 6 h to obtain 0.9 g of a yellow solid.

[0016] Elemental analysis (C 17 h 15 N 7 • 2HCl) Found (calculated, %): C 52.11 (52.43), H 4.56 (4.37), N 25.60 (25.19), Cl 18.17 (17.97).

[0017] According to thermogravimetric analysis, this compound does not contain crystal water and decomposes at 280°C (determined by DTA).

[0018] 1 H-NMR (DMSO-d 6 , ppm) δ: 8.97 (2H, overlapped, 2 and 5 H on the quinoline ring), 8.90 (1H, d, J=8.1Hz, 4 H on the quinoline ring), 8.71 (1H, s, purine ring 8-position H), 8.30 (1H, dd, J=2.0, 9.3Hz, 7-position H on the quinoline ring), 8....

example 2

[0019] Example 2 prepares mesylate (compound II)

[0020] Add compound III (p is tetrahydropyranyl) (1.0g), acetone (6ml) and water (3ml) in 50ml one-necked flask, stir, heat up, add methanesulfonic acid (0.5ml), all solids dissolve , into a clear orange-yellow solution, about 10 minutes later, a yellow solid precipitated out, continued the reaction under reflux for 50 minutes, added water (3ml), the solids were all dissolved again, stopped stirring, and cooled to room temperature naturally. It was filtered, washed with acetone three times, and dried in vacuum at 40°C for 6 hours to obtain 1.2 g of a yellow solid.

[0021] Elemental analysis (C 17 h 15 N 7 ·2CH 3 SO 3 H) Found values ​​(calculated, %): C 41.78 (41.79), H 5.03 (4.95), N 18.15 (17.96), S 11.94 (11.73).

[0022] Differential scanning calorimetry analysis shows that the compound contains crystal water, and thermogravimetric analysis shows that the water content is 6.64%, which confirms that the molecule cont...

example 3

[0026] Example 3 prepares hydrobromide (compound II)

[0027] Add compound III (p is tetrahydropyranyl) (1.0g), 6ml acetone and 3ml water in 50ml one-necked flask, stir, heat up, add 40% HBr (1.5ml), all solids dissolve, become clear After about 10 minutes, a yellow solid precipitated out of the orange solution. The reaction was continued for 50 minutes under reflux, and water (15ml) was added to dissolve the solid again. Stirring was stopped, and the mixture was naturally cooled to room temperature. It was filtered, washed with acetone three times, and dried in vacuum at 40°C for 6 hours to obtain 1.1 g of a yellow solid.

[0028] mp: >250°C.

[0029] 1 H-NMR (DMSO-d 6 , ppm) δ: 9.08 (1H, dd, J=1.6, 5.2Hz, 2-position H on the quinoline ring), 9.04 (1H, d, J=2.4Hz 5-position H on the quinoline ring), 8.94 (1H, d, J=8.4Hz, 4-position H on the quinoline ring), 8.80 (1H, s, 8-position H on the purine ring), 8.37 (1H, dd, J=2.4, 9.6Hz, 7-position H on the quinoline ring ), 8....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention discloses process of forming salt with 2-(6-quinolylamino)-6- cyclopropylamino-9H-purine. Compound III is reacted through deprotection reaction and salt forming reaction to prepare compound II. The process of the present invention is simple and suitable for industrial production.

Description

technical field [0001] The invention relates to the technical field of medicinal chemistry. Specifically, it relates to a method for forming a salt of 2-(6-quinolineamino)-6-cyclopropylamino-9H-purine (compound I). [0002] Background technique [0003] Malignant tumor (cancer) is one of the main diseases that seriously affect human health and threaten human life. No less than 5 million people die from cancer every year in the world. Although some treatment methods such as surgery, radiotherapy, and chemotherapy are available, the cure rate is generally not high. At present, chemotherapy drugs mainly have disadvantages such as poor selectivity and large side effects. Therefore, it has become one of the hot spots to look for anti-tumor drugs with low toxicity, small side effects, high anti-cancer activity and good stability. [0004] It is reported that some purine derivatives have certain antiviral and antitumor activities. For details, see relevant reports in patent...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D473/16C07D215/00
CPCY02P20/55
Inventor 吴章桂袁建勇陈钢
Owner ZHEJIANG MEDICINE CO LTD XINCHANG PHAMACEUTICAL FACTORY